Cytotoxic effects of 15d-PGJ2 against osteosarcoma through ROS-mediated AKT and cell cycle inhibition. - Wikidata - awgldk - TriplyDB

Cytotoxic effects of 15d-PGJ2 against osteosarcoma through ROS-mediated AKT and cell cycle inhibition.

Cytotoxic effects of 15d-PGJ2 against osteosarcoma through ROS-mediated AKT and cell cycle inhibition.

http://www.wikidata.org/entity/Q37718423

about

Cytotoxic effects of 15-deoxy-Δ12,14-prostaglandin J2 alone and in combination with dasatinib against uterine sarcoma in vitro.ROS generation mediates the anti-cancer effects of WZ35 via activating JNK and ER stress apoptotic pathways in gastric cancer.Inhibitive effects of 15-deoxy-Δ(12),(14)-prostaglandin J2 on hepatoma-cell proliferation through reactive oxygen species-mediated apoptosis Substance P Inhibits Hyperosmotic Stress-Induced Apoptosis in Corneal Epithelial Cells through the Mechanism of Akt Activation and Reactive Oxygen Species Scavenging via the Neurokinin-1 Receptor Therapeutic effect of TMZ-POH on human nasopharyngeal carcinoma depends on reactive oxygen species accumulation.Huaier extract synergizes with tamoxifen to induce autophagy and apoptosis in ER-positive breast cancer cells.HER2-induced metastasis is mediated by AKT/JNK/EMT signaling pathway in gastric cancer.Activation of the MAPK/Akt/Nrf2-Egr1/HO-1-GCLc axis protects MG-63 osteosarcoma cells against 15d-PGJ2-mediated cell death.15-deoxy prostaglandin J2, the nonenzymatic metabolite of prostaglandin D2, induces apoptosis in keratinocytes of human hair follicles: a possible explanation for prostaglandin D2-mediated inhibition of hair growth.Extremely low frequency magnetic fields regulate differentiation of regulatory T cells: Potential role for ROS-mediated inhibition on AKT.Alisol B 23-acetate induces autophagic-dependent apoptosis in human colon cancer cells via ROS generation and JNK activation.Divergent proliferation patterns of distinct human hair follicle epithelial progenitor niches in situ and their differential responsiveness to prostaglandin D2.15d-PGJ2 is a new hope for controlling tumor growth.

P2860

Q33744855-356DE686-1C58-4515-901F-C9DAF450E194 Q35742420-81A23710-CA1D-4310-BB78-A69D52C92655 Q35868068-F930E3BA-CE3E-4403-93F5-61FE284C72B2 Q35930971-EB681682-288F-48D1-8DF1-25C9DADE45AB Q36738925-9E51C70F-3D67-43F9-B423-E0BF9E1E192A Q37295565-8C18CE0C-9F69-498C-A80B-E4FBFED1BE85 Q37411309-AD6F22CC-7E1A-43F7-8A5C-C91A0B99F398 Q38800299-93C9D9AE-7CC5-46E1-BFAC-6361EE85F837 Q39761730-777CC925-37DC-4CCD-9343-EE36B302B0CB Q40065271-711B600A-751E-4F3B-863E-9E2812445655 Q42378423-A148C30D-C49D-4C9B-B8EE-30025BF7B56E Q46347479-9F330BEC-FD76-4D7D-9BE3-11675BF232E5 Q52595122-B4540DED-87CA-4A7F-9458-8CC3072E8E1C

P2860

Cytotoxic effects of 15d-PGJ2 against osteosarcoma through ROS-mediated AKT and cell cycle inhibition.

http://www.wikidata.org/entity/Q37718423

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on February 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Cytotoxic effects of 15d-PGJ2 ...... AKT and cell cycle inhibition.

@en

Cytotoxic effects of 15d-PGJ2 ...... AKT and cell cycle inhibition.

@nl

type

label

Cytotoxic effects of 15d-PGJ2 ...... AKT and cell cycle inhibition.

@en

Cytotoxic effects of 15d-PGJ2 ...... AKT and cell cycle inhibition.

@nl

prefLabel

Cytotoxic effects of 15d-PGJ2 ...... AKT and cell cycle inhibition.

@en

Cytotoxic effects of 15d-PGJ2 ...... AKT and cell cycle inhibition.

@nl

P1433

Q37718423-2DBF2FF2-FDA3-4A0B-B49E-FD07BD0D965C

P1476

Q37718423-E883BA4D-B26F-4B02-8F85-99D45C72577B

P2093

Q37718423-04298083-52D6-45B4-903D-B24D734BFDC1

Q37718423-259B9A33-D3EF-4B64-A7CC-913F98729456

Q37718423-27CED72C-D48D-44ED-9F4D-E6F992550EEB

Q37718423-6D6D1E12-429E-4B53-886D-7F0B83F32F13

Q37718423-78180CFD-E419-444F-BCCC-398CCD38FDAB

Q37718423-7EF7A867-441F-4858-9B88-7B6DFB6B30DF

Q37718423-864D0721-A6E2-4C67-B731-AFFAA6A6108A

Q37718423-902A8CE3-CAA3-4255-BAE3-89FAD551B639

Q37718423-9655EA65-0187-4EFF-94EA-CF7D5D8AFB4A

Q37718423-96942F61-A4AF-470B-A1B5-53DCA7969E64

P2860

Q37718423-062A520D-50C9-40C2-90C3-095B8DE7ED32

Q37718423-06E024C8-58B6-4A80-8C2F-7211493956F3

Q37718423-10FC748E-C35D-4FAF-84CF-1059FFC83AEE

Q37718423-177D50E1-2094-4973-A381-41955BA84D8A

Q37718423-1AC34C2A-4E01-4FF4-B12D-6D5955EDC4E3

Q37718423-1EB9C5AA-43F0-4ED0-98F8-ACE5BB9485D2

Q37718423-267F0D44-6F0F-4671-B6DE-0A9388A17181

Q37718423-2896A348-6B86-4E38-BAC3-62E7EB64E63A

Q37718423-2CCA8E02-0D10-4B5F-8745-53B843076EBE

Q37718423-2F3B1C0F-24DD-4838-AB94-A11F79F872E0

P304

Q37718423-E0106521-2938-4B3E-93FA-FB673723CF45

P31

Q37718423-38DF68FB-2B5A-4D3B-9C55-9C3C3B4DA832

P356

Q37718423-98CEFBBF-46E4-423E-80AE-10DF79E930A7

P407

Q37718423-57CE41B9-A160-4A90-A962-3D9460F5DE6B

P433

Q37718423-AFA23BA0-7661-4C7A-B819-EEFE0471C309

P478

Q37718423-E4599450-A8E8-4952-ADFD-B6308316B03E

P577

Q37718423-642271EB-39FF-42E9-B38F-7313C6A19A07

P5875

Q37718423-9877B5F5-B065-4991-803D-4A81D960367F

P698

Q37718423-9BFB9F7D-E374-40F7-93E6-E5DF2FE6B3A0

P921

Q37718423-67F8830A-E69E-4F9D-9ACF-B2B382261DAC

P932

Q37718423-558CCB5E-981D-4B92-9D36-15ADFEDB14BE

P356

ONCOTARGET.1704

P1433

P1476

Cytotoxic effects of 15d-PGJ2 ...... AKT and cell cycle inhibition.

@en

P2093

Cheng-Hwai Tzeng

http://www.w3.org/2001/XMLSchema#string

Chi-Hung Lin

http://www.w3.org/2001/XMLSchema#string

Chien-Lin Liu

http://www.w3.org/2001/XMLSchema#string

Chueh-Chuan Yen

http://www.w3.org/2001/XMLSchema#string

Chung-Der Hsiao

http://www.w3.org/2001/XMLSchema#string

Fang-Yi Yao

http://www.w3.org/2001/XMLSchema#string

Hsei-Wei Wang

http://www.w3.org/2001/XMLSchema#string

Jen-Hwey Chiu

http://www.w3.org/2001/XMLSchema#string

Jir-You Wang

http://www.w3.org/2001/XMLSchema#string

Jonathan A Fletcher

http://www.w3.org/2001/XMLSchema#string

P2860

Vanadate-induced expression of hypoxia-inducible factor 1alpha and vascular endothelial growth factor through phosphatidylinositol 3-kinase/Akt pathway and reactive oxygen species

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

Cancer statistics, 2012

Malignant transformation of mammalian cells initiated by constitutive expression of the polo-like kinase

Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis

15-deoxy-Delta12,14 prostaglandin J2 up-regulates Kruppel-like factor 4 expression independently of peroxisome proliferator-activated receptor gamma by activating the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase sign

The 15-deoxy-Delta12,14-prostaglandin J2 inhibits LPS-stimulated AKT and NF-kappaB activation and suppresses interleukin-6 in osteoblast-like cells MC3T3E-1.

Cytotoxicity of 15-deoxy-Δ(12,14)-prostaglandin J(2) through PPARγ-independent pathway and the involvement of the JNK and Akt pathway in renal cell carcinoma.

Telomerase activity in skeletal sarcomas.

Small interfering RNA library screen of human kinases and phosphatases identifies polo-like kinase 1 as a promising new target for the treatment of pediatric rhabdomyosarcomas.

P304

716-725

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.1704

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2014-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260378465

http://www.w3.org/2001/XMLSchema#string

P698

24566468

http://www.w3.org/2001/XMLSchema#string

P921

P932

3996657

http://www.w3.org/2001/XMLSchema#string